Back to results
US 2026/0234730 A1Published application
Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme q10)
AssigneeBPGbio, Inc.
InventorsNiven Rajin Narain, John Patrick McCook
Life of this patent
Estimating the term…
Abstract
Methods and formulations for treating onocological disorders in humans using Coenzyme Q10 are described.
Claims12
A method for treating or preventing an oncological disorder in a human, comprising:
- administering Coenzyme Q10 (CoQ10) to the human such that treatment or prevention occurs.
2-6. (canceled)
8-25. (canceled)
A method for treating or preventing an aggressive oncological disorder in a human, comprising:
- administering Coenzyme Q10 to the human, such that treatment or prevention of the aggressive oncological disorder occurs.
28-29. (canceled)
A method for treating or preventing an oncological disorder in a human, comprising:
- administering Coenzyme Q10 to the human such that treatment of the oncological disorder occurs, wherein the Coenzyme Q10 is administered such that it is maintained in its oxidized form during treatment.
31-43. (canceled)
46-57. (canceled)
Dependencies are inferred from the claim text.